Description
Disease Indications
Risk of cardiovascular events
Manufacturer
Merck
Usage
Oral
Medicine approved by
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Pharmaceuticals and Medical Devices Agency (PMDA)
Verquvo (vericiguat)
Price range: $100.00 through $350.00
Verquvo (vericiguat) is a medication to reduce the risk of cardiovascular death and heart failure (HF) hospitalization following a hospitalization for heart failure or need for outpatient IV diuretics, in adults with symptomatic chronic HF and ejection fraction less than 45%
Additional information
| Package Tablets | 14 tablets x 2.5 mg, 28 tablets x 2.5 mg, 14 tablets x 5 mg, 28 tablets x 5 mg, 98 tablets x 5 mg, 14 tablets x 10 mg, 98 tablets x 10 mg |
|---|
Related products
-
Vascepa (icosapent ethyl)
$700.00 Select options This product has multiple variants. The options may be chosen on the product page -
Repatha (evolocumab)
Price range: $500.00 through $1,200.00 Select options This product has multiple variants. The options may be chosen on the product page -
Nexletol (bempedoic acid)
$400.00 Select options This product has multiple variants. The options may be chosen on the product page -
Attruby (acoramidis)
$10,000.00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.